内源性多肽在妊娠期糖尿病中的研究进展

doi:10.12280/gjfckx.20210406

摘要/Abstract

摘要：

妊娠期糖尿病（gestational diabetes mellitus,GDM）是一种常见的妊娠期并发症,其发病率在全球范围内日益增高。目前临床上对GDM的诊疗手段仍存在一定的局限性,难以在妊娠前或妊娠早期及时发现并调整生活方式避免GDM的发生、发展。内源性多肽是生物体内普遍存在的一类生命活动调控物质,具有分子质量低、活性高、易于合成和改造等优点作为药物的良好分子基础,是近年来的研究热点。越来越多的研究表明内源性多肽在疾病的预测、诊断和治疗方面都发挥着重要作用,且其在GDM中的研究也日益受到更多的关注。就GDM相关多肽的研究进展进行了综述。

关键词: 糖尿病,妊娠, 糖尿病,2型, 肽类, 预测, 治疗

Abstract:

Gestational diabetes mellitus (GDM) is a common complication of pregnancy, and its incidence rate is increasing worldwide. At present, there are still some limitations in the diagnosis and treatment of GDM. It is difficult to find and adjust the unhealthy lifestyle before or in the early pregnancy period to avoid the occurrence and development of GDM. Endogenous polypeptides is a class of life regulating substances that exist in organisms. They have the advantages of low molecular weight, high activity and easy to synthesize and modificate. As a good molecular basis for drugs, they are becoming a research hotspot in recent years. More and more studies have shown that endogenous peptides plays an important role in the prediction, diagnosis and treatment of diseases, and their research in GDM has attracted more and more attention. This paper aims to review the research progress of GDM related peptides.

Key words: Diabetes,gestational, Diabetes mellitus,type 2, Peptides, Forecasting, Therapy

殷亚东, 刘岚. 内源性多肽在妊娠期糖尿病中的研究进展[J]. 国际妇产科学杂志, 2021, 48(6): 651-655.

YIN Ya-dong, LIU Lan. Research Progress of Endogenous Peptides in Gestational Diabetes Mellitus[J]. Journal of International Obstetrics and Gynecology, 2021, 48(6): 651-655.

参考文献 32

[1]	温学美, 李悦, 陆静. 串联质谱法在合成多肽药物结构确证中的应用进展[J]. 中国药房, 2019,30(20):2876-2880. doi: 10.6039/j.issn.1001-0408.2019.20.27. doi: 10.6039/j.issn.1001-0408.2019.20.27
[2]	Nair S, Guanzon D, Jayabalan N, et al. Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus[J]. J Transl Med, 2021,19(1):360. doi: 10.1186/s12967-021-02999-9. doi: 10.1186/s12967-021-02999-9
[3]	吴红花, 郭晓蕙. 妊娠期糖尿病的前世、今生与未来[J]. 中华糖尿病杂志, 2020,12(7):433-435. doi: 10.3760/cma.j.cn115791-20200401-00190. doi: 10.3760/cma.j.cn115791-20200401-00190
[4]	Simpson S, Smith L, Bowe J. Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus[J]. Curr Opin Pharmacol, 2018,43:59-65. doi: 10.1016/j.coph.2018.08.004. doi: S1471-4892(18)30076-6 pmid: 30199758
[5]	Balachandiran M, Bobby Z, Dorairajan G, et al. Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth[J]. Placenta, 2021,104:71-80. doi: 10.1016/j.placenta.2020.11.008. doi: 10.1016/j.placenta.2020.11.008 pmid: 33285436
[6]	Souvannavong-Vilivong X, Sitticharoon C, Klinjampa R, et al. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM[J]. Acta Diabetol, 2019,56(10):1121-1131. doi: 10.1007/s00592-019-01355-0. doi: 10.1007/s00592-019-01355-0 pmid: 31076892
[7]	Williams MA, Qiu C, Muy-Rivera M, et al. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus[J]. J Clin Endocrinol Metab, 2004,89(5):2306-2311. doi: 10.1210/jc.2003-031201. doi: 10.1210/jc.2003-031201
[8]	Plows JF, Stanley JL, Baker PN, et al. The Pathophysiology of Gestational Diabetes Mellitus[J]. Int J Mol Sci, 2018,19(11):3342. doi: 10.3390/ijms19113342. doi: 10.3390/ijms19113342
[9]	Thagaard IN, Krebs L, Holm JC, et al. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study[J]. Clin Chem Lab Med, 2017,55(11):1805-1812. doi: 10.1515/cclm-2017-0427. doi: 10.1515/cclm-2017-0427 pmid: 28763297
[10]	Musa E, Matjila M, Levitt NS. Kisspeptins and Glucose Homeostasis in Pregnancy: Implications for Gestational Diabetes Mellitus-a Review Article[J]. Reprod Sci, 2021 Jan 4. Epub ahead of print. doi: 10.1007/s43032-020-00437-7. doi: 10.1007/s43032-020-00437-7
[11]	Bowe JE, Hill TG, Hunt KF, et al. A role for placental kisspeptin in β cell adaptation to pregnancy[J]. JCI Insight, 2019,4(20):e124540. doi: 10.1172/jci.insight.124540. doi: 10.1172/jci.insight.124540
[12]	Kautzky-Willer A, Thomaseth K, Ludvik B, et al. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes[J]. Diabetes, 1997,46(4):607-614. doi: 10.2337/diab.46.4.607. doi: 10.2337/diab.46.4.607 pmid: 9075800
[13]	Qiao Q, Wei G, Yao D, et al. Formation of α-helical and β-sheet structures in membrane-bound human IAPP monomer and the resulting membrane deformation[J]. Phys Chem Chem Phys, 2019,21(36):20239-20251. doi: 10.1039/c9cp03151k. doi: 10.1039/c9cp03151k pmid: 31490518
[14]	Potter KJ, Scrocchi LA, Warnock GL, et al. Amyloid inhibitors enhance survival of cultured human islets[J]. Biochim Biophys Acta, 2009,1790(6):566-574. doi: 10.1016/j.bbagen.2009.02.013. doi: 10.1016/j.bbagen.2009.02.013
[15]	Lappas M, Jinks D, Ugoni A, et al. Post-partum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus[J]. J Diabetes, 2015,7(4):506-511. doi: 10.1111/1753-0407.12209. doi: 10.1111/1753-0407.12209
[16]	Liu B, Cai J, Xu Y, et al. Early Diagnosed Gestational Diabetes Mellitus Is Associated With Adverse Pregnancy Outcomes: A Prospective Cohort Study[J]. J Clin Endocrinol Metab, 2020,105(12):dgaa633. doi: 10.1210/clinem/dgaa633. doi: 10.1210/clinem/dgaa633
[17]	O′Malley EG, Reynolds CME, Killalea A, et al. The use of biomarkers at the end of the second trimester to predict Gestational Diabetes Mellitus[J]. Eur J Obstet Gynecol Reprod Biol, 2020,250:101-106. doi: 10.1016/j.ejogrb.2020.04.064. doi: 10.1016/j.ejogrb.2020.04.064
[18]	Falcone V, Kotzaeridi G, Breil MH, et al. Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction?[J]. Diabetes Metab J, 2019,43(6):785-793. doi: 10.4093/dmj.2018.0218. doi: 10.4093/dmj.2018.0218
[19]	Yanagi S, Sato T, Kangawa K, et al. The Homeostatic Force of Ghrelin[J]. Cell Metab, 2018,27(4):786-804. doi: 10.1016/j.cmet.2018.02.008. doi: 10.1016/j.cmet.2018.02.008
[20]	Nunez-Salces M, Li H, Feinle-Bisset C, et al. The regulation of gastric ghrelin secretion[J]. Acta Physiol (Oxf), 2021,231(3):e13588. doi: 10.1111/apha.13588. doi: 10.1111/apha.13588 pmid: 33249751
[21]	Palik E, Baranyi E, Melczer Z, et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance[J]. Diabetes Res Clin Pract, 2007,76(3):351-357. doi: 10.1016/j.diabres.2006.09.005. doi: 10.1016/j.diabres.2006.09.005
[22]	Aydin S, Geckil H, Karatas F, et al. Milk and blood ghrelin level in diabetics[J]. Nutrition, 2007,23(11/12):807-811. doi: 10.1016/j.nut.2007.08.015. doi: 10.1016/j.nut.2007.08.015
[23]	Kimber-Trojnar Ž, Patro-Małysza J, Skórzyńska-Dziduszko KE, et al. Ghrelin in Serum and Urine of Post-Partum Women with Gestational Diabetes Mellitus[J]. Int J Mol Sci, 2018,19(10):3001. doi: 10.3390/ijms19103001. doi: 10.3390/ijms19103001
[24]	Taskin E, Atli B, Kiliç M, et al. Serum, urine, and saliva levels of ghrelin and obestatin pre- and post-treatment in pediatric epilepsy[J]. Pediatr Neurol, 2014,51(3):365-369. doi: 10.1016/j.pediatrneurol.2014.05.014. doi: 10.1016/j.pediatrneurol.2014.05.014 pmid: 25160540
[25]	Fang P, Bo P, Shi M, et al. Circulating galanin levels are increased in patients with gestational diabetes mellitus[J]. Clin Biochem, 2013,46(9):831-833. doi: 10.1016/j.clinbiochem.2012.12.013. doi: 10.1016/j.clinbiochem.2012.12.013
[26]	Zhang Z, Gu C, Fang P, et al. Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus[J]. Peptides, 2014,54:186-189. doi: 10.1016/j.peptides.2014.01.024. doi: 10.1016/j.peptides.2014.01.024
[27]	Lee DH, Silventoinen K, Jacobs DR Jr, et al. gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women[J]. J Clin Endocrinol Metab, 2004,89(11):5410-5414. doi: 10.1210/jc.2004-0505. doi: 10.1210/jc.2004-0505
[28]	Alanbay I, Coksuer H, Ercan M, et al. Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus?[J]. Gynecol Endocrinol, 2012,28(3):208-211. doi: 10.3109/09513590.2011.588756. doi: 10.3109/09513590.2011.588756
[29]	Nashine S, Kenney MC. Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD[J]. Cells, 2020,9(5):1102. doi: 10.3390/cells9051102. doi: 10.3390/cells9051102
[30]	Ma Y, Li S, Wei X, et al. Comparison of serum concentrations of humanin in women with and without gestational diabetes mellitus[J]. Gynecol Endocrinol, 2018,34(12):1064-1067. doi: 10.1080/09513590.2018.1482869. doi: 10.1080/09513590.2018.1482869
[31]	Lee C, Wan J, Miyazaki B, et al. IGF-I regulates the age-dependent signaling peptide humanin[J]. Aging Cell, 2014,13(5):958-961. doi: 10.1111/acel.12243. doi: 10.1111/acel.12243
[32]	Gęca T, Kwaśniewska A. The Influence of Gestational Diabetes Mellitus upon the Selected Parameters of the Maternal and Fetal System of Insulin-Like Growth Factors (IGF-1, IGF-2, IGFBP1-3)-A Review and a Clinical Study[J]. J Clin Med, 2020,9(10):3256. doi: 10.3390/jcm9103256. doi: 10.3390/jcm9103256